Andrew is a Senior Counsel in the Patents team and offers expert counsel on contentious patent and regulatory matters. Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector.
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
作者
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
作者 Andrew Payne
作者 Alison Dennis 以及 Alice Matthews
作者
作者 Colin McCall 以及 Charlie Adams
作者
作者
作者